Pharma and biotech company Panacea Biotec said on Thursday that the firm had entered into a licensing and manufacturing agreement with Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories to manufacture 25 million doses of Sputnik V vaccine.
Panacea signed the agreement with Human Vaccine Limited Liability Company (a subsidiary of RDIF), Generium Joint Stock Company and Dr Reddy’s to produce the Sputnik vaccine. As per the agreement, Panacea would produce Sputnik V vaccine using the ready to fill drug substance manufactured by Generium in Russia and then supply the entire quantity to Dr Reddy’s for distribution in India, the company said in a regulatory filing on the BSE.
- Molbio’s Nipah test kit gets DCGI approval - September 9, 2021
- 61 test negative for Nipah so far: Kerala Health Minister Veena George - September 9, 2021
- RT-PCR accounted for over 70 percent tests conducted in Delhi in last five months - September 9, 2021
- Punjab govt to open 300 new Opioid Assisted Treatment centres to tackle drug addiction - September 9, 2021
- Over five crore people vaccinated in Madhya Pradesh so far - September 9, 2021
- BMC issues new Ganpati festival norms – No pandal darshan, curbs on yatra participants across Mumbai - September 8, 2021
- Early screening & risk assessment through breakthrough technologies - September 8, 2021
- 30 test negative for Nipah so far: Kerala Health Minister Veena George - September 8, 2021
- 88 oxygen generation plants functional in MP, says CM Shivraj Singh Chouhan - September 8, 2021
- Efforts grow to stamp out use of parasite drug for COVID-19 - September 8, 2021